{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:49:11Z","timestamp":1784198951936,"version":"3.55.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of The Peoples Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.compbiomed.2026.111619","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T19:44:11Z","timestamp":1775763851000},"page":"111619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Artificial intelligence for metabolic dysfunction-associated steatotic liver disease diagnosis: A systematic review"],"prefix":"10.1016","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4148-5272","authenticated-orcid":false,"given":"Ruijuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2333-0355","authenticated-orcid":false,"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8966-1934","authenticated-orcid":false,"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2026.111619_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101898","article-title":"Global burden and future trends of metabolic dysfunction-associated Steatotic liver disease: 1990-2021 to 2045","volume":"30","author":"Kan","year":"2025","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.compbiomed.2026.111619_bib3","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41598-018-20166-x","article-title":"A systematic machine learning based approach for the diagnosis of non-alcoholic fatty liver disease risk and progression","volume":"8","author":"Perveen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2026.111619_bib4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41575-025-01045-z","article-title":"\u039cetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment","volume":"22","author":"Byrne","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.119054","article-title":"Liver metabolism in human MASLD: a review of recent advancements using human tissue metabolomics","volume":"400","author":"Flam","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.compbiomed.2026.111619_bib6","first-page":"1","article-title":"Systemic metabolic abnormalities: key drivers of complications and mortality in MASLD","volume":"81","author":"Fan","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib7","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","article-title":"Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi approach","volume":"151","author":"Chew","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.compbiomed.2026.111619_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015473","article-title":"Metabolic-dysfunction-associated steatotic liver disease-its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments","volume":"24","author":"Yanai","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2026.111619_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156080","article-title":"An updated overview on hepatocellular carcinoma in patients with metabolic dysfunction-Associated steatotic Liver disease: trends, pathophysiology and risk-based surveillance","volume":"162","author":"Armandi","year":"2025","journal-title":"Metab., Clin. Exp."},{"key":"10.1016\/j.compbiomed.2026.111619_bib12","article-title":"Application of machine learning and deep learning in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"169","author":"Zhang","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.humpath.2013.11.011","article-title":"Automatic classification of white regions in liver biopsies by supervised machine learning","volume":"45","author":"Vanderbeck","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067203","article-title":"Phenotypes of non-alcoholic fatty liver disease (NAFLD) and all-cause mortality: unsupervised machine learning analysis of NHANES III","volume":"12","author":"Carrillo-Larco","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.compbiomed.2026.111619_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.hbpd.2021.08.004","article-title":"Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: an extended study","volume":"20","author":"Liu","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.compbiomed.2026.111619_bib16","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s10620-017-4721-9","article-title":"Accurate identification of fatty liver disease in data warehouse utilizing natural language processing","volume":"62","author":"Redman","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.compbiomed.2026.111619_bib17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/jgh.15415","article-title":"Artificial intelligence in precision medicine in hepatology","volume":"36","author":"Su","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12876-020-01585-5","article-title":"Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis","volume":"21","author":"Decharatanachart","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13040-024-00391-z","article-title":"Deep learning-based approaches for multi-omics data integration and analysis","volume":"17","author":"Ballard","year":"2024","journal-title":"BioData Min."},{"key":"10.1016\/j.compbiomed.2026.111619_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jum.15693","article-title":"Liver fat assessment in multiview sonography using transfer learning with convolutional neural networks","volume":"41","author":"Byra","year":"2022","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.20.24415","article-title":"Liver steatosis categorization on contrast-enhanced CT using a fully automated deep learning volumetric segmentation tool: evaluation in 1204 healthy adults using unenhanced CT as a reference standard","volume":"217","author":"Pickhardt","year":"2021","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib22","first-page":"305","article-title":"A 3D deep neural network for liver volumetry in 3T contrast-enhanced MRI","volume":"193","author":"Winther","year":"2021","journal-title":"R\u00f6fo"},{"key":"10.1016\/j.compbiomed.2026.111619_bib23","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fradi.2025.1634165","article-title":"The evolution of artificial intelligence technology in non-alcoholic fatty liver disease","volume":"5","author":"He","year":"2025","journal-title":"Front. Radiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib25","article-title":"Pathological evolution and internal medicine management of Nonalcoholic Fatty Liver Disease (NAFLD) in the era of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","volume":"17","author":"Hashim","year":"2025","journal-title":"Cureus"},{"issue":"Suppl 1","key":"10.1016\/j.compbiomed.2026.111619_bib26","first-page":"S23","article-title":"Diagnosis and non-invasive assessment of MASLD in type 2 diabetes and obesity","volume":"59","author":"Chan","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.compbiomed.2026.111619_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s43856-025-00780-3","article-title":"Deep proteome profiling of metabolic dysfunction-associated steatotic liver disease","volume":"5","author":"Boel","year":"2025","journal-title":"Commun. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib64","first-page":"e88","article-title":"Screening and identifying hepatobiliary diseases through deep learning using ocular images: a prospective, multicentre study, lancet digit","volume":"3","author":"Xiao","year":"2021","journal-title":"Health"},{"key":"10.1016\/j.compbiomed.2026.111619_bib83","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/liv.15818","article-title":"Machine-learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD-related liver fibrosis","volume":"44","author":"Fan","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.compbiomed.2026.111619_bib54","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/hepr.13628","article-title":"Artificial intelligence\/neural network system for the screening of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"51","author":"Okanoue","year":"2021","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.compbiomed.2026.111619_bib48","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/jamia\/ocab003","article-title":"Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis","volume":"28","author":"Docherty","year":"2021","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"10.1016\/j.compbiomed.2026.111619_bib34","first-page":"12704","article-title":"A predictive model for the diagnosis of non-alcoholic fatty liver disease based on an integrated machine learning method","volume":"13","author":"Ma","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.compbiomed.2026.111619_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11154-021-09681-x","article-title":"Applications of artificial intelligence (AI) in researches on non-alcoholic fatty liver disease(NAFLD) : a systematic review","volume":"23","author":"Li","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.compbiomed.2026.111619_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cca.2017.09.020","article-title":"NAFL screening score: a basic score identifying ultrasound-diagnosed non-alcoholic fatty liver","volume":"475","author":"Zhou","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.compbiomed.2026.111619_bib30","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cgh.2016.03.034","article-title":"Development and validation of the Framingham Steatosis index to identify persons with hepatic Steatosis","volume":"14","author":"Long","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.10.011","article-title":"The ability of the Framingham Steatosis Index (FSI) to predict non-alcoholic fatty liver disease (NAFLD): a cohort study","volume":"45","author":"Motamed","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib32","article-title":"Modeling the natural history of fatty liver using lifestyle-related risk factors: effects of body mass index (BMI) on the life-course of fatty liver","volume":"14","author":"Aizawa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2026.111619_bib33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s44320-025-00134-0","article-title":"Longitudinal big biological data in the AI era","volume":"21","author":"Mardinoglu","year":"2025","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib35","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2026.111619_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100561","article-title":"Multi-omics profiling for health","volume":"22","author":"Babu","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.compbiomed.2026.111619_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg.2018.4","article-title":"Integrative omics for health and disease","volume":"19","author":"Karczewski","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.compbiomed.2026.111619_bib38","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41591-023-02401-9","article-title":"Integrated multi-omics for rapid rare disease diagnosis on a national scale","volume":"29","author":"Lunke","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41575-018-0007-8","article-title":"Systems biology in hepatology: approaches and applications","volume":"15","author":"Mardinoglu","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib40","first-page":"1","article-title":"Decoding the triglyceride-glucose index in metabolic dysfunction-associated steatotic liver disease: integrative insights from mendelian randomization, cross-tissue transcriptomics, and spatial multi-omics","volume":"25","author":"He","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.compbiomed.2026.111619_bib41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41575-024-00915-2","article-title":"Spatial genomics: mapping human steatotic liver disease","volume":"21","author":"Matchett","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41571-025-00991-6","article-title":"Artificial intelligence in digital pathology - time for a reality check","volume":"22","author":"Aggarwal","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41591-021-01614-0","article-title":"AI in health and medicine","volume":"28","author":"Rajpurkar","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib44","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1038\/s41591-024-03284-0","article-title":"Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Jamialahmadi","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178426","article-title":"Early insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) patients: an observational study on polygenic risk and liver biomarkers","volume":"26","author":"Torre","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2026.111619_bib46","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cgh.2024.08.009","article-title":"Performance of AI-Enabled electrocardiogram in the prediction of metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Udompap","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2024.07.005","article-title":"A machine learning algorithm for stratification of risk of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease","volume":"129","author":"Shibata","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib49","article-title":"AI in medicine: where are we now and where are we going?","volume":"3","author":"Shandhi","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000908","article-title":"Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD","volume":"80","author":"Charu","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-023-02602-2","article-title":"An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease","volume":"29","author":"Kendall","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-17386-3","article-title":"Diagnostic accuracy of artificial intelligence models for imaging detection of hepatic steatosis through systematic review and meta analysis","volume":"15","author":"Nivethitha","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2026.111619_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2025.100205","article-title":"Artificial intelligence in hepatology: a comprehensive scoping review of clinical applications, challenges, and future directions","volume":"4","author":"Eskandar","year":"2025","journal-title":"iLIVER"},{"key":"10.1016\/j.compbiomed.2026.111619_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/srep31587","article-title":"Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models","volume":"6","author":"Chiappini","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2026.111619_bib56","first-page":"40699281","article-title":"A comparison of the predictive value of 12 body composition markers for metabolic dysfunction-associated steatotic liver disease, At-Risk metabolic dysfunction-associated steatohepatitis, and increased liver stiffness in a general population setting","author":"Kleef","year":"2025","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2025.100765","article-title":"Development of a neural network to detect hepatic steatosis in metabolic dysfunction-associated steatotic liver disease","volume":"5","author":"Hirooka","year":"2026","journal-title":"Gastro hep advances"},{"key":"10.1016\/j.compbiomed.2026.111619_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062439","article-title":"Novel algorithm for non-invasive assessment of fibrosis in NAFLD","volume":"8","author":"Sowa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2026.111619_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.11.032","article-title":"Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH","volume":"82","author":"Abdurrachim","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/s10916-020-01693-5","article-title":"Non-alcoholic fatty liver and liver fibrosis predictive analytics: risk prediction and machine learning techniques for improved preventive medicine","volume":"45","author":"Goldman","year":"2021","journal-title":"J. Med. Syst."},{"key":"10.1016\/j.compbiomed.2026.111619_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1210\/clinem\/dgaf111","article-title":"Machine learning-based biomarker identification for early diagnosis of metabolic dysfunction-associated steatotic liver disease","volume":"110","author":"Boullion","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.compbiomed.2026.111619_bib62","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1111\/liv.16085","article-title":"FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH","volume":"44","author":"Mart\u00ednez-Arenas","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.compbiomed.2026.111619_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.846118","article-title":"A machine learning based framework to identify and classify non-alcoholic fatty liver disease in a large-scale population","volume":"10","author":"Ji","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.compbiomed.2026.111619_bib65","article-title":"Adiponectin as a predictor of metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease: a 17-Year Korean cohort study","volume":"J","author":"Yang","year":"2025","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.compbiomed.2026.111619_bib66","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1038\/s41467-024-48956-0","article-title":"Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD","volume":"15","author":"Koppen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2026.111619_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111636","article-title":"Machine learning-based identification of potentially novel non-alcoholic fatty liver disease biomarkers","volume":"9","author":"Shafiha","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.compbiomed.2026.111619_bib68","article-title":"Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib69","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20230211","article-title":"Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration","volume":"96","author":"Wei","year":"2023","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib70","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.compbiomed.2026.111619_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1125829","article-title":"Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning","volume":"14","author":"Cao","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib72","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1210\/clinem\/dgae060","article-title":"Machine learning identifies metabolic dysfunction-associated steatotic liver disease in patients with diabetes mellitus","volume":"109","author":"Nabrdalik","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.compbiomed.2026.111619_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70416","article-title":"Machine learning models for screening steatosis in MASLD: an international validation study","volume":"45","author":"Ye","year":"2025","journal-title":"Liver Int."},{"key":"10.1016\/j.compbiomed.2026.111619_bib74","article-title":"Open-source code to extend early-onset sepsis calculator accessibility","volume":"6","author":"Weijden","year":"2024","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.compbiomed.2026.111619_bib75","first-page":"261","article-title":"Current modalities of fibrosis assessment in non-alcoholic fatty liver disease","volume":"5","author":"Cheah","year":"2017","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib76","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib77","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jhep.2022.01.011","article-title":"Complexity of ballooned hepatocyte feature recognition: defining a training atlas for artificial intelligence-based imaging in NAFLD","volume":"76","author":"Brunt","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib78","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.cgh.2019.12.025","article-title":"High-throughput, machine learning-based quantification of steatosis, inflammation, ballooning, and fibrosis in biopsies from patients with nonalcoholic fatty liver disease","volume":"18","author":"Forlano","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib79","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41591-024-03301-2","article-title":"Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis","volume":"31","author":"Harrison","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib80","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.2024.1447","article-title":"Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease","volume":"331","author":"Lin","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.compbiomed.2026.111619_bib81","first-page":"1194","article-title":"MAFLD fibrosis score: using routine measures to identify advanced fibrosis in metabolic-associated fatty liver disease, aliment","volume":"58","author":"Cheung","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.compbiomed.2026.111619_bib82","first-page":"2","article-title":"ALADDIN: a machine learning approach to enhance the prediction of significant fibrosis or higher in metabolic dysfunction-associated steatotic liver disease","volume":"121","author":"Alkhouri","year":"2025","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.11.013","article-title":"Improved assessment of donor liver steatosis using Banff consensus recommendations and deep learning algorithms","volume":"80","author":"Gambella","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41575-023-00843-7","article-title":"Digital pathology for nonalcoholic steatohepatitis assessment","volume":"21","author":"Sanyal","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib86","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease: current status and future perspective","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.compbiomed.2026.111619_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214436","article-title":"Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective","volume":"14","author":"Canbay","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2026.111619_bib88","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11695-010-0204-1","article-title":"A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis","volume":"21","author":"Younossi","year":"2011","journal-title":"Obes. Surg."},{"key":"10.1016\/j.compbiomed.2026.111619_bib89","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal","volume":"58","author":"Machado","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.29721","article-title":"Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib91","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S2468-1253(20)30252-1","article-title":"A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study","volume":"5","author":"Harrison","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib92","doi-asserted-by":"crossref","DOI":"10.1186\/s12938-019-0742-2","article-title":"Ultrasonic liver steatosis quantification by a learning-based acoustic model from a novel shear wave sequence","volume":"18","author":"Shi","year":"2019","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.compbiomed.2026.111619_bib93","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41569-021-00527-2","article-title":"Applications of artificial intelligence in cardiovascular imaging","volume":"18","author":"Sermesant","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib94","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnmt.106.037846","article-title":"Principles of CT: radiation dose and image quality","volume":"35","author":"Goldman","year":"2007","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2021.102154","article-title":"United adversarial learning for liver tumor segmentation and detection of multi-modality non-contrast MRI","volume":"73","author":"Zhao","year":"2021","journal-title":"Med. Image Anal."},{"key":"10.1016\/j.compbiomed.2026.111619_bib96","first-page":"16","article-title":"Automatic weighing attribute to retrieve similar lung cancer nodules","author":"Ferreira De Lucena","year":"2016","journal-title":"BMC Med. Inf. Decis. Making"},{"key":"10.1016\/j.compbiomed.2026.111619_bib97","first-page":"127","article-title":"Artificial intelligence in cancer imaging: clinical challenges and applications","volume":"69","author":"Bi","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.compbiomed.2026.111619_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2022.102444","article-title":"Recent advances and clinical applications of deep learning in medical image analysis","volume":"79","author":"Chen","year":"2022","journal-title":"Med. Image Anal."},{"key":"10.1016\/j.compbiomed.2026.111619_bib99","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.acra.2019.12.024","article-title":"Creating artificial images for radiology applications using generative adversarial networks (GANs) - a systematic review","volume":"27","author":"Sorin","year":"2020","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/jamacardio.2024.4991","article-title":"Artificial intelligence-guided lung ultrasound by nonexperts","volume":"10","author":"Baloescu","year":"2025","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jhep.2024.09.010","article-title":"Recognizing significant role of microvascular invasion in postoperative aggressive recurrence of early hepatocellular carcinoma","volume":"82","author":"Zhang","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib128","first-page":"1","article-title":"Proton density fat fraction for diagnosis of metabolic dysfunction-associated steatotic liver disease","volume":"83","author":"Wolfson","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib112","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10278-025-01394-w","article-title":"PBCS-ConvNeXt: convolutional network-based automatic diagnosis of non-alcoholic fatty liver in abdominal ultrasound images","volume":"38","author":"Chiang","year":"2025","journal-title":"J. Imaging Inform. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib111","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejim.2024.03.004","article-title":"Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography","volume":"125","author":"Santoro","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib110","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.3748\/wjg.v28.i22.2494","article-title":"Accurate and generalizable quantitative scoring of liver steatosis from ultrasound images scalable deep learning","volume":"28","author":"Li","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003149","article-title":"Predicting and elucidating the etiology of fatty liver disease: a machine learning modeling and validation study in the IMI DIRECT cohorts","volume":"17","author":"Atabaki-Pasdar","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib102","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1148\/radiol.2021204288","article-title":"Quantification of liver fat content with CT and MRI: state of the art","volume":"301","author":"Starekova","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040790","article-title":"Performance of ultrasound techniques and the potential of artificial intelligence in the evaluation of hepatocellular carcinoma and non-alcoholic fatty liver disease","volume":"13","author":"Lupsor-Platon","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.compbiomed.2026.111619_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070720","article-title":"Towards clinical application of artificial intelligence in ultrasound imaging","volume":"9","author":"Komatsu","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.compbiomed.2026.111619_bib105","author":"Ballestri"},{"key":"10.1016\/j.compbiomed.2026.111619_bib106","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10396-024-01509-w","article-title":"Convolutional neural network classification of ultrasound parametric images based on echo-envelope statistics for the quantitative diagnosis of liver steatosis","volume":"52","author":"Isshiki","year":"2025","journal-title":"J. Med. Ultrason."},{"key":"10.1016\/j.compbiomed.2026.111619_bib107","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00330-025-12117-8","article-title":"Ultrasound-based fat fraction for detection of hepatic steatosis and quantification of liver fat content using liver biopsy as the reference standard","volume":"36","author":"Ji","year":"2025","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib108","article-title":"Diagnostic accuracy of convolutional neural networks in classifying hepatic steatosis from B-mode ultrasound images: a systematic review with meta-analysis and novel validation in a community setting in Telangana, India","volume":"40","author":"Jagadeesh","year":"2025","journal-title":"Lancet Reg. Health Southeast Asia"},{"key":"10.1016\/j.compbiomed.2026.111619_bib109","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1148\/radiol.2020191160","article-title":"Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat with radiofrequency ultrasound data using one-dimensional convolutional neural networks","volume":"295","author":"Han","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib113","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.242564","article-title":"Metabolic dysfunction-associated steatotic liver disease at quantitative US: international prospective study","volume":"316","author":"Huang","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1148\/radiol.241963","article-title":"Photon-counting detector CT: a promising tool for noninvasive liver fat assessment","volume":"312","author":"Wildman-Tobriner","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib115","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1109\/TMI.2018.2845918","article-title":"H-DenseUNet: hybrid densely connected UNet for liver and tumor segmentation from CT volumes","volume":"37","author":"Li","year":"2018","journal-title":"IEEE Trans. Med. Imag."},{"key":"10.1016\/j.compbiomed.2026.111619_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28123","article-title":"Spleen volume is independently associated with non-alcoholic fatty liver disease, liver volume and liver fibrosis","volume":"10","author":"Helgesson","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.compbiomed.2026.111619_bib117","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1007\/s00330-024-10660-4","article-title":"Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters","volume":"34","author":"Yoo","year":"2024","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib118","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2214\/AJR.23.29651","article-title":"Detection of moderate hepatic steatosis on portal venous phase contrast-enhanced CT: evaluation using an automated artificial intelligence tool","volume":"221","author":"Pickhardt","year":"2023","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib119","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.32216","article-title":"CT-Based body composition measures and systemic disease: a population-level analysis using artificial intelligence tools in over 100,000 patients","volume":"224","author":"Pooler","year":"2025","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib120","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/adc96e","article-title":"Characterization of fibrotic liver tissue microstructure for predicting shear wave speed variability: a machine-learning-based computational study","volume":"70","author":"Miller","year":"2025","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib121","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1148\/radiol.2018180763","article-title":"Development and validation of a deep learning system for staging liver fibrosis by using contrast agent-enhanced CT images in the liver","volume":"289","author":"Choi","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110461","article-title":"A novel fast kilovoltage switching dual-energy computed tomography technique with deep learning: utility for non-invasive assessments of liver fibrosis","volume":"155","author":"Wada","year":"2022","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib123","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00261-025-05137-x","article-title":"Quantification of hepatic steatosis on post-contrast computed tomography scans using artificial intelligence tools","volume":"51","author":"Derstine","year":"2025","journal-title":"Abdom. Radiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib124","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.210268","article-title":"Fully automated and explainable liver segmental volume ratio and spleen segmentation at CT for diagnosing cirrhosis","volume":"4","author":"Lee","year":"2022","journal-title":"Radiol. Artif. Intell."},{"key":"10.1016\/j.compbiomed.2026.111619_bib125","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.compbiomed.2026.111619_bib126","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41568-020-00327-9","article-title":"Designing deep learning studies in cancer diagnostics","volume":"21","author":"Kleppe","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.compbiomed.2026.111619_bib127","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gutjnl-2021-324264","article-title":"Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease","volume":"71","author":"Tamaki","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.compbiomed.2026.111619_bib129","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2214\/AJR.23.29607","article-title":"Deep learning for inference of hepatic proton density fat fraction from T1-Weighted In-Phase and opposed-phase MRI: retrospective analysis of population-based trial data","volume":"221","author":"Wang","year":"2023","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102881","article-title":"Development of fully automated models for staging liver fi brosis using non-contrast MRI and artificial intelligence: a retrospective multicenter study","volume":"77","author":"Li","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.compbiomed.2026.111619_bib131","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/neuonc\/nox092","article-title":"Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab","volume":"19","author":"Grossmann","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib132","first-page":"905","article-title":"Research progress of radiomics with artificial intelligence in precise diagnosis and treatment of hepatocellular carcinoma","volume":"28","author":"Li","year":"2020","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.compbiomed.2026.111619_bib133","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1148\/radiol.2019190372","article-title":"Lymph node metastasis prediction from primary breast cancer US images using deep learning","volume":"294","author":"Zhou","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib134","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12519-024-00814-1","article-title":"Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis","volume":"20","author":"Lee","year":"2024","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.compbiomed.2026.111619_bib135","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/HEP.0000000000001368","article-title":"AASLD practice statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children","volume":"82","author":"Xanthakos","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib136","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3350\/cmh.2025.0718","article-title":"Pediatric metabolic dysfunction-associated steatotic liver disease and the gut microbiome: from research landscape to targeted modulation","volume":"32","author":"Jiang","year":"2026","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib137","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/kjm2.12850","article-title":"Development of a diagnostic support system for the fibrosis of nonalcoholic fatty liver disease using artificial intelligence and deep learning","volume":"40","author":"Preechathammawong","year":"2024","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.compbiomed.2026.111619_bib138","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186422","article-title":"MASLD in children: integrating epidemiological trends with mechanistic and translational advances","volume":"135","author":"Schwimmer","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.compbiomed.2026.111619_bib139","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i28.108321","article-title":"Construction of a community-based primary screening and hospital-based confirmatory screening pathway in pediatric nonalcoholic fatty liver disease","volume":"31","author":"Yao","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12519-023-00704-y","article-title":"Development and validation of a novel non-invasive test for diagnosing nonalcoholic fatty liver disease in Chinese children","volume":"20","author":"Qin","year":"2024","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.compbiomed.2026.111619_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1625864","article-title":"Development and validation of a non-invasive prediction model for identifying high-risk children with metabolic dysfunction-associated fatty liver disease","volume":"13","author":"Xiaowu","year":"2025","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.compbiomed.2026.111619_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/children11101230","article-title":"Reference range of quantitative MRI metrics corrected T1 and liver fat content in children and young adults: pooled participant analysis","volume":"11","author":"Shumbayawonda","year":"2024","journal-title":"Children"},{"key":"10.1016\/j.compbiomed.2026.111619_bib143","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"Do","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2026.111619_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70137","article-title":"Consensus statement on metabolic dysfunction-associated steatotic liver disease in children and adolescents from the joint TASL-TSPGHAN expert committee","volume":"9","author":"Lin","year":"2025","journal-title":"JGH open"},{"key":"10.1016\/j.compbiomed.2026.111619_bib145","article-title":"Pediatric MASLD in China: epidemiology, screening, diagnosis, and management","volume":"64","author":"Li","year":"2025","journal-title":"Lancet Reg. Health West. Pac."},{"key":"10.1016\/j.compbiomed.2026.111619_bib146","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41575-023-00800-4","article-title":"Lifestyle interventions in nonalcoholic fatty liver disease","volume":"20","author":"Younossi","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib147","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.molmed.2024.05.013","article-title":"Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Cherubini","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib148","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41574-021-00538-6","article-title":"Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease","volume":"17","author":"Lefebvre","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib149","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i23.107100","article-title":"Hepatocellular carcinoma in patients without cirrhosis","volume":"31","author":"Sato-Espinoza","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41575-025-01089-1","article-title":"Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma","volume":"22","author":"Lau","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib151","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230255","article-title":"Dual-energy CT deep learning radiomics to predict Macrotrabecular-Massive hepatocellular carcinoma","volume":"308","author":"Li","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib152","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5306\/wjco.v15.i2.243","article-title":"Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib153","doi-asserted-by":"crossref","first-page":"67","DOI":"10.21037\/tgh-24-41","article-title":"Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver disease","volume":"9","author":"Liang","year":"2024","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib154","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2214\/AJR.22.27749","article-title":"CT-Derived body composition assessment as a prognostic tool in oncologic patients: from opportunistic research to artificial intelligence-based clinical implementation","volume":"219","author":"Bates","year":"2022","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jacr.2024.12.011","article-title":"Opportunistic detection of hepatocellular carcinoma using noncontrast CT and deep learning artificial intelligence","volume":"22","author":"Peng","year":"2025","journal-title":"J. Am. Coll. Radiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib156","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/HEP.0000000000000904","article-title":"Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease","volume":"81","author":"Tateishi","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib157","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jhep.2019.11.017","article-title":"Advances in resection and transplantation for hepatocellular carcinoma","volume":"72","author":"Vibert","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.692774","article-title":"An adaptive transfer-learning-based deep cox neural network for hepatocellular carcinoma prognosis prediction","volume":"11","author":"Chai","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib159","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13073-021-00930-x","article-title":"DeepProg: an ensemble of deep-learning and machine-learning models for prognosis prediction using multi-omics data","volume":"13","author":"Poirion","year":"2021","journal-title":"Genome Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib161","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1109\/JBHI.2024.3451331","article-title":"Preoperative prediction of microvascular invasion in hepatocellular carcinoma from multi-sequence magnetic resonance imaging based on deep fusion representation learning","volume":"29","author":"Ma","year":"2025","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"10.1016\/j.compbiomed.2026.111619_bib162","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i34.111541","article-title":"Multiparametric magnetic resonance imaging of deep learning-based super-resolution reconstruction for predicting histopathologic grade in hepatocellular carcinoma","volume":"31","author":"Wang","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib163","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(25)00403-9","article-title":"Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial","volume":"405","author":"Yau","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.compbiomed.2026.111619_bib164","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1158\/1535-7163.MCT-23-0470","article-title":"Integrated imaging probe and bispecific antibody development enables in vivo targeting of Glypican-3-Expressing hepatocellular carcinoma","volume":"23","author":"Habibollahi","year":"2024","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.compbiomed.2026.111619_bib165","article-title":"Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver-induced hepatocellular carcinoma by driving ITGB1-mediated \u03b2-catenin activation","volume":"135","author":"Gurung","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.compbiomed.2026.111619_bib166","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jmri.28982","article-title":"MRI-based radiomics and deep learning in biological characteristics and prognosis of hepatocellular carcinoma: opportunities and challenges","volume":"59","author":"Xia","year":"2024","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.compbiomed.2026.111619_bib167","first-page":"4","article-title":"Defining noninvasive criteria for indicating drug therapy in metabolic dysfunction-associated steatotic liver disease in clinical practice","volume":"24","author":"Olveira","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib168","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib169","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1038\/s41591-025-03799-0","article-title":"Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"31","author":"Kj\u00e6r","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib170","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41591-025-04130-7","article-title":"MASLD as a complication of obesity must include liver risk stratification","volume":"32","author":"Rinella","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib172","doi-asserted-by":"crossref","first-page":"60","DOI":"10.17925\/EE.2023.19.1.60","article-title":"Resmetirom: an orally administered, smallmolecule, liver-directed, \u03b2-selective THR agonist for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"19","author":"Karim","year":"2023","journal-title":"TouchREVIEWS Endocrinol"},{"key":"10.1016\/j.compbiomed.2026.111619_bib173","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41575-023-00796-x","article-title":"Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach","volume":"20","author":"Brennan","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib174","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s42255-025-01318-6","article-title":"Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease","volume":"7","author":"Kim","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.compbiomed.2026.111619_bib175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abk0855","article-title":"Risk assessment with gut microbiome and metabolite markers in NAFLD development","volume":"14","author":"Leung","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.compbiomed.2026.111619_bib176","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2024.12.045","article-title":"Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD","volume":"82","author":"Barb","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107997","article-title":"15-keto-PGE 2 alleviates nonalcoholic steatohepatitis through its covalent modification of NF-\u03baB factors","volume":"26","author":"Hee","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.compbiomed.2026.111619_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/nu16142220","article-title":"Management of metabolic-associated fatty liver disease\/metabolic dysfunction-associated steatotic liver disease: from medication therapy to nutritional interventions","volume":"16","author":"Beygi","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.compbiomed.2026.111619_bib179","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ueg2.70055","article-title":"Key predictors of relevant weight loss in patients with metabolic dysfunction-associated steatotic liver disease","volume":"13","author":"Pugliese","year":"2025","journal-title":"United Eur. Gastroenterol. J."},{"key":"10.1016\/j.compbiomed.2026.111619_bib180","article-title":"Bariatric surgery for metabolic dysfunction-associated steatotic liver disease (MASLD): current knowledge of mechanisms","author":"Liu","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib181","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17474124.2025.2607008","article-title":"Guideline comparison for fatty liver disease: european (EASL-EASD-EASO) and Asian (APASL) perspectives","volume":"20","author":"Abenavoli","year":"2026","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib182","article-title":"Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group, Ann","volume":"30","author":"Diaz","year":"2025","journal-title":"Hepatol"},{"key":"10.1016\/j.compbiomed.2026.111619_bib183","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib184","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70150","article-title":"AI-Based platelet-independent noninvasive test for liver fibrosis in MASLD patients","volume":"9","author":"Wakabayashi","year":"2025","journal-title":"JGH Open"},{"key":"10.1016\/j.compbiomed.2026.111619_bib185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MED.0000000000000935","article-title":"Emerging concepts in the diagnosis and management of metabolically associated steatotic liver disease","volume":"32","author":"Das","year":"2025","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.compbiomed.2026.111619_bib186","article-title":"Development of a diagnostic model for MASLD and identification of daidzein as the potential drug using bioinformatics analysis and experiments","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2025.103438","article-title":"A simple laboratory-based machine learning model accurately predicts advanced liver fibrosis in metabolic dysfunction-associated steatotic liver disease patients","volume":"16","author":"Sharma","year":"2026","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2025.103184","article-title":"Artificial intelligence for predictive diagnostics, prognosis, and decision support in MASLD, hepatocellular carcinoma, and digital pathology","volume":"16","author":"Dunn","year":"2026","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib189","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-025-05317-9","article-title":"Physics-aware imaging AI for quantitative MASLD biomarker mapping: a systematic review of deep learning and radiomics across ultrasound, CT, and MRI","author":"Maghsoudi","year":"2025","journal-title":"Abdom. Radiol."},{"key":"10.1016\/j.compbiomed.2026.111619_bib190","first-page":"26","article-title":"Multicenter prospective cohort study on clinical outcomes and fibrosis patterns in biopsy-proven steatotic liver disease subtypes","volume":"S0016-5085","author":"Jang","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1016\/j.compbiomed.2026.111619_bib191","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000628","article-title":"The evolving role of liver biopsy: current applications and future prospects","volume":"9","author":"Gopal","year":"2025","journal-title":"Hepatol. Commun."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482526001824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482526001824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T13:05:21Z","timestamp":1778331921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482526001824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":191,"alternative-id":["S0010482526001824"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111619","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence for metabolic dysfunction-associated steatotic liver disease diagnosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111619"}}